Monitor for potential follow-up selling or commentary ahead of next earnings; coordinated C-suite exits may signal caution despite no public negative news. Compare with historical patterns — if this deviates from routine selling, it could foreshadow downside risk.
Price Chart
Executive Summary
Three corporate insiders at PTC Therapeutics sold shares in a coordinated 7-day window, including the Chief Medical Officer and Chief Technical Operations Officer, totaling $1.29 million in open-market transactions. The sales represent a modest but notable insider selling cluster, with executives and a director reducing holdings at current market prices.
Key Financial Metrics
Key Facts
- EVP & Chief Medical Officer Scott Golden sold 10,000 shares for $633,800 in an open-market transaction.
- Director Stephanie Okey sold 6,333 shares for $401,385.54 in an open-market transaction.
- Chief Technical Operations Officer Neil Almstead sold 3,989 shares for $252,822.82 in an open-market transaction.
- All transactions occurred on 2026-03-05 at $63.38 per share, totaling $1.288 million in aggregate.
- Total value of the cluster is approximately 0.025% of the company's $5.2B market cap — modest in scale but notable due to participation by C-suite executives.
Financial Impact
$1.288 million in insider selling, representing 0.025% of market capitalization
Risk Factors
- Perception of insider lack of confidence, especially with Chief Medical Officer selling.
- Potential for negative sentiment amplification if no fundamental explanation is provided.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-PTCT-1773091238112 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 6w ago | Insider Cluster | $69.82 $65.26 | ▼ −6.53% | ▼ −6.00% | $63.46 (−9.11%) |
Jul 16, 2026 11w ago | Press Release | $78.52 $71.97 | ▲ +8.34% | ▲ +11.96% | $63.46 (+19.18%) |
Jul 16, 2026 11w ago | Insider Cluster | $78.52 $71.97 | ▼ −8.34% | ▼ −11.96% | $63.46 (−19.18%) |
Jul 13, 2026 11w ago | Insider Cluster | $81.33 $74.63 | ▼ −8.24% | ▼ −11.42% | $63.46 (−21.97%) |
Jul 8, 2026 12w ago | Insider Cluster | $88.57 $69.21 | ▼ −21.86% | ▼ −25.13% | $63.46 (−28.35%) |
Jun 26, 2026 13w ago | Insider Cluster | $81.57 $76.82 | ▼ −5.82% | ▼ −5.54% | $63.46 (−22.20%) |
Jun 16, 2026 15w ago | 8-K | $73.27 $78.06 | ▲ +6.54% | ▲ +6.34% | $63.46 (−13.39%) |
Jun 9, 2026 16w ago | 8-K | $73.35 $89.55 | ▲ +22.09% | ▲ +18.46% | $63.46 (−13.48%) |
May 19, 2026 19w ago | Insider Cluster | $71.02 $78.98 | ▲ +11.21% | ▲ +10.47% | $63.46 (−10.64%) |
May 15, 2026 19w ago | Insider Cluster | $70.15 $73.27 | ▲ +4.45% | ▲ +2.87% | $63.46 (−9.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access